Cuba vs Lower-middle income (World Bank): Pneumococcal conjugate second or third-dose vaccines (PCVc)
Cuba
99.0%
in 2025
Lower-middle income (World Bank)
81.0%
in 2025
Cuba rank
1st
Lower-middle income (World Bank) rank
4th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Cuba
- Lower-middle income (World Bank)
How they compare
Cuba currently reports 99.0% against 81.0% in Lower-middle income (World Bank), a difference of 18.0%.
That makes Cuba's figure about 1.2 times Lower-middle income (World Bank)'s.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Lower-middle income (World Bank) ahead.
Cuba ranks 1st and Lower-middle income (World Bank) ranks 4th of 194 countries.
Lower-middle income (World Bank) has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cuba | Lower-middle income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 24.9% | 24.9% | Lower-middle income (World Bank) |
| 2020s | 16.5% | 68.0% | 51.5% | Lower-middle income (World Bank) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Cuba or Lower-middle income (World Bank)?
- Cuba, at 99.0% against 81.0% in Lower-middle income (World Bank) as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Cuba and Lower-middle income (World Bank)?
- 18.0%, with Cuba ahead.
- How many years of comparable data are there for Cuba and Lower-middle income (World Bank)?
- 18 years are reported by both, from 2008 to 2025.
- How do Cuba and Lower-middle income (World Bank) rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Cuba ranks 1st and Lower-middle income (World Bank) ranks 4th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.